100 related articles for article (PubMed ID: 24296047)
1. Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogs of Linezolid with antimicrobial activity.
Parisi OI; Fiorillo M; Caruso A; Cappello AR; Saturnino C; Puoci F; Panno A; Dolce V; El-Kashef H; Sinicropi MS
Int J Pharm; 2014 Jan; 461(1-2):163-70. PubMed ID: 24296047
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial properties and elution kinetics of linezolid from polymethylmethacrylate.
Snir N; Meron-Sudai S; Deshmukh AJ; Dekel S; Ofek I
Orthopedics; 2013 Nov; 36(11):e1412-7. PubMed ID: 24200446
[TBL] [Abstract][Full Text] [Related]
3. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
4. Biofilm inhibition of linezolid-like Schiff bases: synthesis, biological activity, molecular docking and in silico ADME prediction.
Sangshetti JN; Khan FA; Patil RH; Marathe SD; Gade WN; Shinde DB
Bioorg Med Chem Lett; 2015 Feb; 25(4):874-80. PubMed ID: 25592714
[TBL] [Abstract][Full Text] [Related]
5. Novel promising linezolid analogues: rational design, synthesis and biological evaluation.
De Rosa M; Zanfardino A; Notomista E; Wichelhaus TA; Saturnino C; Varcamonti M; Soriente A
Eur J Med Chem; 2013 Nov; 69():779-85. PubMed ID: 24099997
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of calcium phosphate biomaterial loaded with linezolid for osseous bone defect implantation.
Gautier H; Plumecocq A; Amador G; Weiss P; Merle C; Bouler JM
J Biomater Appl; 2012 Mar; 26(7):811-28. PubMed ID: 20876634
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
8. [Linezolid, a drug in a new class of antibiotics].
Knudsen JD; Skov RL
Ugeskr Laeger; 2003 Mar; 165(13):1349-53. PubMed ID: 12703280
[No Abstract] [Full Text] [Related]
9. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
10. Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci.
Wu J; Jiang TT; Su JR; Li L
Chin Med J (Engl); 2013 Jul; 126(14):2670-5. PubMed ID: 23876894
[TBL] [Abstract][Full Text] [Related]
11. Use of linezolid in children. Introduction.
Kaplan SL
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S151-2. PubMed ID: 14520139
[No Abstract] [Full Text] [Related]
12. Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid.
Ammazzalorso A; Amoroso R; Bettoni G; Fantacuzzi M; De Filippis B; Giampietro L; Maccallini C; Paludi D; Tricca ML
Farmaco; 2004 Sep; 59(9):685-90. PubMed ID: 15337433
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives.
Vieira M; Pinheiro C; Fernandes R; Noronha JP; Prudêncio C
Microbiol Res; 2014 Apr; 169(4):287-93. PubMed ID: 23928379
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):655-9. PubMed ID: 23642281
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antibacterial activities of novel oxazolidinones.
Srivastava BK; Jain MR; Solanki M; Soni R; Valani D; Gupta S; Mishra B; Takale V; Kapadnis P; Patel H; Pandya P; Patel JZ; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):683-93. PubMed ID: 17611001
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives.
Palumbo Piccionello A; Musumeci R; Cocuzza C; Fortuna CG; Guarcello A; Pierro P; Pace A
Eur J Med Chem; 2012 Apr; 50():441-8. PubMed ID: 22365410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
